Erasca Correlations
| ERAS Stock | USD 2.76 0.06 2.22% |
The current 90-days correlation between Erasca Inc and Eliem Therapeutics is -0.04 (i.e., Good diversification). The correlation of Erasca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Erasca Correlation With Market
Weak diversification
The correlation between Erasca Inc and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and DJI in the same portfolio, assuming nothing else is changed.
Erasca |
Moving against Erasca Stock
| 0.35 | KZR | Kezar Life Sciences | PairCorr |
| 0.44 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.41 | HD | Home Depot | PairCorr |
| 0.38 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.33 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.31 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
| -0.01 | 0.87 | -0.52 | 0.83 | -0.66 | ELYM | ||
| -0.01 | -0.17 | 0.1 | 0.11 | 0.01 | HCWB | ||
| 0.87 | -0.17 | -0.52 | 0.72 | -0.57 | SCPH | ||
| -0.52 | 0.1 | -0.52 | -0.42 | 0.49 | MIST | ||
| 0.83 | 0.11 | 0.72 | -0.42 | -0.6 | MCRB | ||
| -0.66 | 0.01 | -0.57 | 0.49 | -0.6 | LUMO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Erasca Stock performing well and Erasca Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Erasca's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELYM | 3.92 | (0.95) | 0.00 | (5.36) | 0.00 | 6.21 | 34.87 | |||
| HCWB | 13.22 | 4.45 | 0.42 | (1.48) | 7.39 | 22.00 | 352.85 | |||
| SCPH | 2.68 | (0.82) | 0.00 | (0.32) | 0.00 | 4.30 | 20.70 | |||
| MIST | 1.92 | 0.21 | 0.13 | 0.25 | 1.60 | 7.19 | 18.66 | |||
| MCRB | 4.68 | 0.01 | (0.02) | 0.25 | 5.68 | 10.00 | 28.84 | |||
| LUMO | 2.77 | 0.61 | 0.15 | (3.14) | 2.60 | 6.35 | 26.13 |
Erasca Corporate Management
| Michael Varney | Scientific Development | Profile | |
| Lisa TesvichBonora | Chief Officer | Profile | |
| Nik Chetwyn | VP Operations | Profile | |
| CPA MS | VP Fin | Profile | |
| Wei MD | Chief Officer | Profile | |
| JD Esq | General Secretary | Profile | |
| Esq JD | General Secretary | Profile |